Novanta (NASDAQ:NOVT – Get Free Report) released its quarterly earnings results on Tuesday. The technology company reported $0.74 earnings per share for the quarter, beating analysts’ consensus estimates of $0.68 by $0.06, Zacks reports. Novanta had a return on equity of 15.20% and a net margin of 6.52%. The business’s quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.74 EPS. Novanta updated its Q2 2025 guidance to 0.680-0.780 EPS.
Novanta Price Performance
Novanta stock traded down $3.59 during midday trading on Tuesday, hitting $116.43. The company’s stock had a trading volume of 202,965 shares, compared to its average volume of 200,944. Novanta has a 12 month low of $98.76 and a 12 month high of $187.12. The company has a quick ratio of 1.81, a current ratio of 2.79 and a debt-to-equity ratio of 0.61. The stock’s 50-day moving average price is $125.50 and its 200-day moving average price is $147.12. The company has a market capitalization of $4.19 billion, a PE ratio of 70.05 and a beta of 1.51.
Wall Street Analyst Weigh In
Separately, Robert W. Baird dropped their price target on shares of Novanta from $169.00 to $160.00 and set a “neutral” rating on the stock in a research report on Monday, March 3rd.
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Further Reading
- Five stocks we like better than Novanta
- Insider Buying Explained: What Investors Need to Know
- The Top-Ranked Insider Buys From April by Market Cap
- What Investors Need to Know About Upcoming IPOs
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
- The Role Economic Reports Play in a Successful Investment Strategy
- Hims & Hers Stock Rises on Fundamentals and Squeeze Potential
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.